After having cancer, travelling can become more than a getaway. It can be part of your emotional recovery. Rest, joy, and ...

In this Q&A, Dr. Dina Khalaf, a clinical associate professor in the University of Florida Division of Hematology and Oncology ...

A phase 1 trial treated 15 patients with breast cancer that spread to the spinal fluid using a vaccine made from their own immune cells. One patient is now more than three years from diagnosis.

Children with diffuse midline glioma who took Keppra lived a median of 20.96 months, compared with 9.92 months for those who did not, a new study found.

Perioperative durvalumab plus FLOT reduced mortality versus FLOT alone in 948 patients, yielding 2-year OS 76% versus 70% and ...

Cancer exercise specialist and breast cancer survivor Jennifer Tipton demonstrates a series of simple movements that can be adapted based on how you're feeling. The routine includes gentle stretches, ...

Progression-free survival reached 14.3 months with Enhertu versus 8.3 months with chemotherapy plus Keytruda in HER2-mutant ...

Follow Jennifer Tipton’s simple exercises to keep your body moving.

The FDA granted final approval to OMCAZIO, a new cabozantinib capsule formulation for certain patients with kidney, liver and ...

Patients with early-stage EGFR-mutated non-small cell lung cancer (NSCLC) who took Tagrisso (osimertinib) for three years ...

In the phase 3 DESTINY-Lung04 trial, patients with HER2-mutant advanced non-small cell lung cancer treated with Enhertu went ...

Biomarker-matched agents increasingly supplant empiric chemo, with approvals typically starting in refractory metastatic ...